- Redmann, V, Lamb CA, Hwang S, Orchard RC, Kim S, Razi M, Milam A, Park S, Yokoyama CC, Kambal A, Kreamalmeyer D, Bosch MK, Xiao M, Green K, Kim J, Pruett-Miller SM, Ornitz DM, Allen PM, Beatty WL, Schmidt RE, DiAntonio A, Tooze SA, Virgin HW. Clec16a is Critical for Autophagolysosome Function and Purkinje cell survival. Scientific Reports. 2016 Mar.
- Gardner T, Cohen T, Redmann V, Lau Z, Felsenfeld D, Tortorella, D. Development of a high-content screen for the identification of inhibitors directed against the early steps of the cytomegalovirus infectious cycle. Antiviral Research: 2015 Jan.
- Noriega VM, Gardner TJ, Redmann V, Bongers G, Lira SA, Tortorella D. Human cytomegalovirus US28 facilitates cell-to-cell viral dissemination. Viruses. 2014 Mar.
- Everts B, Amiel E, Huang SC, Smith AM, Chang CH, Lam WY, Redmann V, Freitas TC, Blagih J, van der Windt GJ, Artyomov MN, Jones RG, Pearce EL, Pearce EJ. TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKɛ supports the anabolic demands of dendritic cell activation. Nature Immunology: 2014 April.
- Redmann, V, Gardner T, Lau Z, Morohashi K, Felsenfeld D, Tortorella D. Novel class of potential therapeutics that target ricin retrograde translocation. Toxins: 2013 Dec.
- Gardner T, Bolovan-Fritts C, Teng M, Redmann V, Kraus T, Sperling R, Moran T, Britt W, Weinberger L and Tortorella D. Development of a high-throughput assay to measure the neutralization capability of anti-CMV antibodies. Clinical and Vaccine Immunology: 2013 April.
- Noriega V, Redmann V, Gardner T and Tortorella D. Diverse immune evasion strategies by human cytomegalovirus. Immunologic research: 2012 Dec.
- Redmann V, Oresic K, Tortorella LL, Cook JP, Lord M and Tortorella D. Ricin toxin A chains in human cells utilizes selective cellular factors. Journal of Biological Chemistry: 2011 Jun.